Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 6:34 pm Purchase |
2025-04-15 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 2,542,603 34.100% |
1,492,550 (+142.14%) |
Filing History |
| 2025-02-24 4:15 pm Purchase |
2025-02-20 | 13D | Allurion Technologies Inc. ALUR |
RTW Investments, LP | 1,050,053 17.600% |
903,389 (+615.96%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW Investments, LP | 6,859,823 9.800% |
940,388 (+15.89%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 5,310,033 9.990% |
1,178,988 (+28.54%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Establishment Labs Holdings Inc. ESTA |
RTW Investments, LP | 2,822,216 9.990% |
328,078 (+13.15%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Neurogene Inc. NGNE |
RTW Investments, LP | 1,498,829 9.990% |
363,573 (+32.03%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RTW Investments, LP | 5,640,593 9.990% |
2,285,768 (+68.13%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
RTW Investments, LP | 8,705,501 5.200% |
-5,002,005 (-36.49%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 1,024,335 9.990% |
-8,196,337 (-88.89%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 1,113,002 2.500% |
-2,148,494 (-65.87%) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | PepGen Inc. PEPG |
RTW Investments, LP | 3,193,097 9.800% |
3,193,097 (New Position) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
RTW Investments, LP | 12,368,334 5.900% |
-6,137,222 (-33.16%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RTW Investments, LP | 5,218,641 5.100% |
-1,600,000 (-23.47%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
RTW Investments, LP | 3,002,370 4.900% |
-2,194,649 (-42.23%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW Investments, LP | 4,051,365 8.400% |
-438,231 (-9.76%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Immatics N.V. IMTX |
RTW Investments, LP | 6,540,540 5.500% |
-3,459,460 (-34.59%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | CUTERA INC CUTRQ |
RTW Investments, LP | 0 0.000% |
-1,817,585 (Position Closed) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Geron Corporation GERN |
RTW Investments, LP | 0 0.000% |
-44,111,916 (Position Closed) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
RTW Investments, LP | 2,712,097 6.000% |
2,712,097 (New Position) |
Filing History |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
RTW Investments, LP | 3,621,996 6.200% |
1,389,236 (+62.22%) |
Filing History |